William Shakespeare files SEC Form 4 disclosures for Theseus Pharmaceuticals, Inc.. They have made 1 open-market trade across 1 company since 2021, most recently 2023-11-06.
CIK 0001879255
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| THRX | 639,408 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2023-11-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| THRX | BUY | 2021-10-12 | 2021-10-14 | $16.00 | $10K | +0.4% | +6.3% | -37.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.